AIM ImmunoTech Inc. Stock Chart

AIM ImmunoTech Inc. (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About AIM ImmunoTech Inc.

LSE
Market Cap
$7.15M
Shares Out.
2.71M
Sector
Health Technology
Industry
Pharmaceuticals: Major

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.

www.aimimmuno.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0A4Y.GB (0A4Y.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart